Instrument Inactif

Autres langues Good Works II Acquisition Corp. Nasdaq

Actions

GWII.U

US38216G2030

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Good Works II Acquisition Corp.(NasdaqCM:GWII) dropped from NASDAQ Composite Index	15/03/23
Good Works II Acquisition : Other Event - Form 8-K	22/02/23
GOOD WORKS II ACQUISITION CORP. : Other Events (form 8-K)	22/02/23
GOOD WORKS II ACQUISITION CORP. : Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	16/02/23
Direct Biologics LLC cancelled the acquisition of Good Works II Acquisition Corp. from I-B Good Works 2, LLC and others in a reverse merger transaction.	15/02/23
GOOD WORKS II ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	20/01/23
GOOD WORKS II ACQUISITION CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	29/12/22
GOOD WORKS II ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	25/10/22
Good Works II Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	25/10/22
Good Works II Acquisition, Direct Biologics Enter SPAC Merger Deal	13/10/22
Direct Biologics to list in U.S. via $1 billion SPAC	13/10/22
Good Works II Acquisition Corp. and Direct Biologics, LLC Announce a Definitive Agreement for a Business Combination	13/10/22
GOOD WORKS II ACQUISITION CORP. : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	13/10/22
Good Works II Acquisition Signs Letter of Intent for Business Combination With Direct Biologics	27/09/22
Good Works II Acquisition Corp. Announces Letter of Intent for a Business Combination with Direct Biologics, LLC	27/09/22
GOOD WORKS II ACQUISITION CORP. : Other Events, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	27/09/22
Direct Biologics LLC announced that it expects to receive $100 million in funding from IB Investments 1 LLC, and other investors	27/09/22
Direct Biologics LLC entered into a non-binding letter of intent to acquire Good Works II Acquisition Corp. from I-B Good Works 2, LLC and others for approximately $630 million in a reverse merger transaction.	27/09/22
GOOD WORKS II ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	27/07/22
Good Works II Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	27/07/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Good Works II Acquisition Corp. Nasdaq

Actions

GWII.U

US38216G2030

Autres langues

Filtres